Double blind randomized controlled trial to assess the efficacy of carbon dioxide insufflation during gastric endoscopic submucosal dissection

Double blind randomized controlled trial to assess the efficacy of carbon dioxide insufflation during gastric endoscopic submucosal dissection - Double blind randomized controlled trial to assess the efficacy of carbon dioxide insufflation during gastric endoscopic submucosal dissection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006444

Enrollment

100

Registered

2011-12-31

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer

Interventions

insufflation of CO2 or Air Multi-detector row computed tomography (MDCT) was carried out immediately after ESD.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who undergo gastric ESD

Exclusion criteria

Exclusion criteria: inability to provide informed consent, severe chronic obstructive pulmonary disease, and synchronous multiple lesions.

Design outcomes

Primary

Measure	Time frame
post-ESD pain assessed by using 100 mm visual analog scale	—

Secondary

Measure	Time frame
dosage of sedative agents safety clinical course treatment results gas volume in gastrointestinal tract	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026